Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Ginkgo Bioworks Holdings Inc (NYSE: DNA) was $9.78 for the day, down -11.97% from the previous closing price of $11.11. In other words, the price has decreased by -$11.97 from its previous closing price. On the day, 1.28 million shares were traded. DNA stock price reached its highest trading level at $10.78 during the session, while it also had its lowest trading level at $9.76.
Ratios:
Our analysis of DNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.79 and its Current Ratio is at 5.79. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.56.
Raymond James Downgraded its Outperform to Mkt Perform on November 14, 2023, whereas the target price for the stock was revised from $3.50 to $2.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 10 ’25 when Che Austin bought 99 shares for $10.78 per share.
Coen Steven P. sold 324 shares of DNA for $3,797 on Jan 06 ’25. The insider now owns 7,288 shares after completing the transaction at $11.72 per share. On Jan 06 ’25, another insider, Dmytruk Mark E., who serves as the insider of the company, sold 645 shares for $11.72 each. As a result, the insider received 7,558 and left with 33,216 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNA now has a Market Capitalization of 562143616 and an Enterprise Value of 362181696. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.58 while its Price-to-Book (P/B) ratio in mrq is 0.61. Its current Enterprise Value per Revenue stands at 1.662 whereas that against EBITDA is -0.689.
Stock Price History:
Over the past 52 weeks, DNA has reached a high of $64.40, while it has fallen to a 52-week low of $5.26. The 50-Day Moving Average of the stock is 8.47%, while the 200-Day Moving Average is calculated to be -40.15%.
Shares Statistics:
DNA traded an average of 1.25M shares per day over the past three months and 1322460 shares per day over the past ten days. A total of 41.37M shares are outstanding, with a floating share count of 36.49M. Insiders hold about 33.02% of the company’s shares, while institutions hold 47.97% stake in the company. Shares short for DNA as of 1734048000 were 7173693 with a Short Ratio of 5.90, compared to 1731628800 on 7315814. Therefore, it implies a Short% of Shares Outstanding of 7173693 and a Short% of Float of 21.55.
